Clinical Trial Update: Tissue Analysis After Tumor Ablation for Liver Metastases Leading to Immediate Retreatment [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial evaluating tissue analysis after ablation of liver metastases to guide immediate retreatment; the study is in Phase 2/3 and currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Metastases

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Liver Metastases | Phase 2, Phase 3 | Status: RECRUITING